OSSIFI
OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and accelerate return to function. Unlike orthobiologic competitors, OssiFi utilizes a proprietary small molecule to modulate bone growth through Sclerostin inhibition. Its carrier matrix is intended to combine excellent handling characteristics, ideal release kinetics and cellular in-growth capabilities with demonstrated biocompatibility. The company plans to conduct rigorous scientific and clinical studies to prove superior efficacy and safety over standard of care. This evidence, which is lacking in competitive biomaterials, will ultimately drive their commercial success and support the best patient care possible.
OSSIFI
Industry:
Health Care Medical Medical Device
Founded:
2011-01-01
Address:
Kansas City, Missouri, United States
Country:
United States
Website Url:
http://www.ossifi.com
Total Employee:
11+
Status:
Active
Contact:
(913)945-6763
Total Funding:
1.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Nginx Amazon Google Apps For Business GoDaddy DNS
Similar Organizations
Accure Acne
Accure is a medical device company committed to developing a novel and impactful solution for acne sufferers.
G Medical Innovations
G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.ossifi.com Semrush global rank: 5.29 M Semrush visits lastest month: 1.56 K
- Host name: staticip2.multiscreensite.com
- IP address: 100.24.208.97
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
